Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8 - Oxford BioMedica Plc

21 Jan 2005 12:30

Prelude Trust PLC21 January 2005 FORM 8.1/8.3 Lodge with a RIS or Newstrack if appropriate and the Takeover Panel. Use aseparate form for each class of securities in which dealings have been made. Date of Disclosure20 January 2005............................................................... DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERSAND MERGERS Date of dealing20 January 2005............................................................... Dealing in (name of company)Oxford BioMedica Plc.......................................................... 1. Class of securities (eg ordinary shares)Ordinary Shares............................................................... 2. Amount Amount Pricebought sold per unit 750,000 22.833 3. Resultant total of the same class owned or controlled (and percentage ofclass)16,937,346.................... (4.55%) 4. Party making disclosure Prelude Trust plc......................................................... 5. EITHER (a) Name of purchaser / vendor (Note 1) Prelude Trust plc......................................................... OR (b) if dealing for discretionary client(s), name of fund managementorganisation ................................................................... ......... 6. Reason for disclosure (Note 2) ............................................................................. (a) associate of (i) offeror (Note 3) NO (ii) offeree company NO Specify which category or categories of associate (1-8 overleaf) ............................................................................ If category (8), explain ............................................................................ (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of theclass of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above ........................................................................... (Also print name of signatory) Giorgio Reggiani .......................................................... Telephone and Extension number 01954 299080............................................................... Note 1. Specify owner, not nominee or vehicle company. If relevant, also identifycontroller of owner, eg where an owner normally acts on instructions of acontroller Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or with anassociate of any offeror or of the offeree company in relation to relevantsecurities, details of such arrangement must be disclosed, as required by Note 6on Rule 8. Note 5. It may be necessary, particularly when disclosing derivative transactions, toappend a sheet to this disclosure form so that all relevant information can begiven. Note 6. In the case of an average price bargain, each underlying trade should bedisclosed. For full details of disclosure requirements, see Rule 8 of the Code. If indoubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:020 7638 0129. Email: monitoring@disclosure.org.uk DEFINITION OF ASSOCIATE It is not practicable to define associate in terms which would cover all thedifferent relationships which may exist in an offer. The term associate isintended to cover all persons (whether or not acting in concert) who directly orindirectly own or deal in the shares of an offeror or the offeree company in anoffer and who have (in addition to their normal interests as shareholders) aninterest or potential interest, whether commercial, financial or personal, inthe outcome of the offer. Without prejudice to the generality of the foregoing, the term associate willnormally include the following:- (1) an offeror's or the offeree company's parent, subsidiaries and fellowsubsidiaries, and their associated companies, and companies of which suchcompanies are associated companies (for this purpose ownership or control of 20%or more of the equity share capital of a company is regarded as the test ofassociated company status); (2) banks and financial and other professional advisers (including stockbrokers)* to an offeror, the offeree company or any company covered in (1), includingpersons controlling#, controlled by or under the same control as such banks,financial and other professional advisers; (3) the directors (together with their close relatives and related trusts) of anofferor, the offeree company or any company covered in (1); (4) the pension funds of an offeror, the offeree company or any company coveredin (1); (5) any investment company, unit trust or other person whose investments anassociate manages on a discretionary basis, in respect of the relevantinvestment accounts; (6) a person who owns or controls 5% or more of any class of relevant securities(as defined in paragraphs (a) to (d) in Note 2 on Rule 8) issued by an offeroror an offeree company, including a person who as a result of any transactionowns or controls 5% or more. When two or more persons act pursuant to anagreement or understanding (formal or informal) to acquire or control suchsecurities, they will be deemed to be a single person for the purpose of thisparagraph. Such securities managed on a discretionary basis by an investmentmanagement group will, unless otherwise agreed by the Panel, also be deemed tobe those of a single person (see Note 8 on Rule 8); and (7) a company having a material trading arrangement with an offeror or theofferee company. Paragraphs (1)-(7) are typical cases. Paragraph (8) below is a category to coverassociate status not within (1)-(7). (8) Other. Notes * References to a "bank" do not apply to a bank whose sole relationship with aparty to an offer is the provision of normal commercial banking services or suchactivities in connection with the offer as confirming that cash is available,handling acceptances and other registration work.References to "financial and other professional advisers (includingstockbrokers)", in relation to a party to an offer, do not include anorganisation which has stood down, because of a conflict of interest orotherwise, from acting for that party in connection with the offer. If theorganisation is to have a continuing involvement with that party during theoffer, the Panel must be consulted. Unless the Panel is satisfied that theinvolvement is entirely unconnected with the offer, the above exclusion will notnormally apply. # The normal test for whether a person is controlled by, controls or is underthe same control as another person will be by reference to the definition ofcontrol contained in the Code. There may be other circumstances which the Panelwill regard as giving rise to such a relationship (eg where a majority of theequity share capital is owned by another person who does not have a majority ofthe voting rights); in cases of doubt, the Panel should be consulted. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jun 20244:02 pmRNSHolding(s) in Company
27th Jun 20241:57 pmRNSPerson Closely Associated Dealing
24th Jun 20245:44 pmRNSResult of Annual General Meeting
21st Jun 20243:11 pmRNSHolding(s) in Company
20th Jun 202412:24 pmRNSHolding(s) in Company
20th Jun 202410:45 amRNSHolding(s) in Company
20th Jun 20249:15 amRNSHolding(s) in Company
19th Jun 20248:00 amRNSAdmission of Shares and Total Voting Rights
18th Jun 20247:00 amRNSSubscription of shares by Institut Mérieux
3rd Jun 20247:00 amRNSTotal Voting Rights
15th May 20243:52 pmRNS2024 Annual General Meeting Notification
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20245:00 pmRNS2023 Annual Report and Accounts
29th Apr 20249:38 amRNSPrelim Results for Y/E 2023 - REPLACEMENT
29th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
2nd Apr 20247:00 amRNSTotal Voting Rights
20th Mar 20247:00 amRNSUpdate on CDMO Services
11th Mar 20247:00 amRNSBoard Changes
5th Mar 20247:00 amRNSUpdated Financial Guidance and 2023 Trading
1st Mar 20247:00 amRNSTotal Voting Rights
15th Feb 20247:00 amRNSAppointment of Joint Corporate Broker
1st Feb 20244:48 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSBlock Listing Application
30th Jan 20247:00 amRNSTotal Voting Rights
29th Jan 20248:38 amRNSCompletion of Transaction
26th Jan 20243:09 pmRNSBlock listing application
4th Jan 202411:49 amRNSDirector Declaration
2nd Jan 20247:00 amRNSBlock Listing Return
2nd Jan 20247:00 amRNSTotal Voting Rights
13th Dec 20237:00 amRNS2023 AGM Post Meeting Update Statement
7th Dec 20237:00 amRNSBusiness Update
4th Dec 20237:00 amRNSSigning of agreement to acquire ABL Europe
1st Dec 20237:00 amRNSTotal Voting Rights
24th Nov 20237:00 amRNSGrant of options
16th Nov 20233:32 pmRNSPDMR Dealing – Replacement
14th Nov 20231:43 pmRNSPDMR Dealings
1st Nov 20237:00 amRNSTotal Voting Rights
24th Oct 20236:17 pmRNSHolding(s) in Company
24th Oct 20235:36 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSHolding(s) in Company
11th Oct 202311:33 amRNSPDMR Dealings
4th Oct 20235:09 pmRNSGrant of Options
2nd Oct 20233:06 pmRNSTotal Voting Rights
27th Sep 202312:03 pmRNSPDMR / PCA Dealing
26th Sep 20233:47 pmRNSPDMR Dealings
22nd Sep 202311:42 amRNSPDMR Dealings
20th Sep 202311:42 amRNSDirector Dealings
20th Sep 20237:01 amRNSProject Aquarius

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.